Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer

BACKGROUND: Although 1% has been used as cut-off for estrogen receptor (ER) positivity, several studies have reported that tumors with ER < 1% have characteristics similar to those with 1% ≤ ER < 10%. We hypothesized that in patients with human epidermal growth factor 2 (HER2)-negative breast...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Oncol
Main Authors: Fujii, T., Kogawa, T., Dong, W., Sahin, A. A., Moulder, S., Litton, J. K., Tripathy, D., Iwamoto, T., Hunt, K. K., Pusztai, L., Lim, B., Shen, Y., Ueno, N. T.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834134/
https://ncbi.nlm.nih.gov/pubmed/28961844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx397
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki